Recent News

• 06.13.2026 - Arcadia Biosciences Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
• 06.12.2026 - Arcadia Biosciences Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
• 08.14.2025 - Arcadia Biosciences Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
• 08.14.2025 - Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
• 05.08.2025 - Q1 2025 Financial Results and Business Highlights Conference Call
• 05.08.2025 - Arcadia Biosciences Announces First Quarter 2025 Financial Results and Business Highlights
• 05.08.2025 - Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
• 04.29.2025 - Arcadia Biosciences Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call
• 04.29.2025 - Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call
• 03.20.2025 - Q4 2024 Financial Results and Business Highlights Conference Call

Recent Filings

• 07.02.2026 - 8-K Current report
• 06.26.2026 - D Notice of Exempt Offering of Securities
• 06.26.2026 - S-3 Registration statement under Securities Act of 1933
• 06.15.2026 - 8-K Current report
• 06.15.2026 - EX-99.1 EX-99.1
• 05.15.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.14.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.14.2026 - 8-K Current report
• 05.14.2026 - EX-99.1 EX-99.1
• 04.30.2026 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]